Ozack Aps

entrepreneurs that move from research to clinical development phases and beyond go into a very regulated area with options as well as pitfalls. chances of success are increased significantly if a company is aware of all this and more good medicines will reach the patients that way. ozack wants to increase progress by infusing our knowledge to navigate the regulatory maze through development of medicine within all phases of drug development. we will • work out regulatory strategies with the company to choose the best route and mitigate risk • glue clinical, nonclinical, and cmc data together into a well understood story • ensure successful liaising with health authorities as partners rather than opponents